Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Jun-19 5:11 PM View:  | Housley Andrece Chief Financial Officer | INSYS Therapeutics, Inc. (INSY) | 17-Apr-19 | Grant | 3,992 | -- | -- | 23% 17.0K to 20.99K | |
| 05-Jun-19 5:31 PM View: | Long Andrew G Chief Executive Officer Director | INSYS Therapeutics, Inc. (INSY) | 17-Apr-19 | Grant | 12,475 | -- | -- | 25% 49.6K to 62.08K | |
| 23-Apr-19 7:15 PM View: | Mahboob Vaseem Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 135% 6.0K to 14.08K | |
| 19-Apr-19 9:34 PM View: | Bohlen Elizabeth Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 135% 6.0K to 14.08K | |
| 23-Apr-19 7:07 PM View: | Vishnoi Rohit Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 51% 16.0K to 24.08K | |
| 23-Apr-19 7:09 PM View: | Lapalme Pierre Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 73% 11.0K to 19.08K | |
| 23-Apr-19 7:10 PM View: | Meyer Steven J Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 13% 60.08K to 68.17K | |
| 23-Apr-19 7:14 PM View: | Vanhove Geertrui Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 135% 6.0K to 14.08K | |
| 23-Apr-19 7:16 PM View: | Bohlen Elizabeth Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 135% 6.0K to 14.08K | |
| 19-Apr-19 9:46 PM View: | Vishnoi Rohit Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 51% 16.0K to 24.08K | |
| 19-Apr-19 9:32 PM View: | Lapalme Pierre Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 73% 11.0K to 19.08K | |
| 19-Apr-19 9:35 PM View: | Mahboob Vaseem Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 135% 6.0K to 14.08K | |
| 19-Apr-19 9:31 PM View: | Meyer Steven J Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 13% 60.08K to 68.17K | |
| 19-Apr-19 9:30 PM View: | Vanhove Geertrui Director | INSYS Therapeutics, Inc. (INSY) | 04-Mar-19 | Grant | 8,083 | -- | -- | 135% 6.0K to 14.08K | |
| 19-Apr-19 9:38 PM View: | Nance Mark E Chief Legal Officer & Gen Cnsl | INSYS Therapeutics, Inc. (INSY) | 25-Jan-19 | Grant | 10,000 | -- | -- | 67% 15.0K to 25.0K | |
| 23-Apr-19 7:11 PM View: | Long Andrew G Chief Financial Officer | INSYS Therapeutics, Inc. (INSY) | 25-Jan-19 | Grant Duplicate | 29,000 | -- | -- | 141% 20.6K to 49.6K | |
| 23-Apr-19 7:15 PM View: | Nance Mark E Chief Legal Officer & Gen Cnsl | INSYS Therapeutics, Inc. (INSY) | 25-Jan-19 | Grant Duplicate | 10,000 | -- | -- | 67% 15.0K to 25.0K | |
| 23-Apr-19 7:12 PM View: | Motahari Saeed President & CEO Director | INSYS Therapeutics, Inc. (INSY) | 25-Jan-19 | Grant Duplicate | 59,206 | -- | -- | 83% 70.99K to 130.19K | |
| 19-Apr-19 9:41 PM View: | Long Andrew G Chief Financial Officer | INSYS Therapeutics, Inc. (INSY) | 25-Jan-19 | Grant | 29,000 | -- | -- | 141% 20.6K to 49.6K | |
| 19-Apr-19 9:40 PM View: | Motahari Saeed President & CEO Director | INSYS Therapeutics, Inc. (INSY) | 25-Jan-19 | Grant | 59,206 | -- | -- | 83% 70.99K to 130.19K | |
| 12-Oct-18 4:43 PM View: | Nance Mark E Chief Legal Officer & Gen Cnsl | INSYS Therapeutics, Inc. (INSY) | 10-Oct-18 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 07-Aug-18 3:10 PM View: | Long Andrew G Chief Financial Officer | INSYS Therapeutics, Inc. (INSY) | 07-Aug-18 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 09-Aug-18 4:13 PM View: | Bohlen Elizabeth Director | INSYS Therapeutics, Inc. (INSY) | 07-Aug-18 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 14-May-18 5:50 PM View: | Tambi Brian Director | INSYS Therapeutics, Inc. (INSY) | 10-May-18 | Market Option Sale | 162,504 | $6.41 | $1,041,650.00 | (98%) 166.5K to 4.0K | 23% |
| 14-May-18 5:50 PM View: | Tambi Brian Director | INSYS Therapeutics, Inc. (INSY) | 10-May-18 | Option Exercise | 162,504 | $2.15 | $349,866.00 | 4063% 4.0K to 166.5K | |
| 14-May-18 5:50 PM View: | Tambi Brian Director | INSYS Therapeutics, Inc. (INSY) | 10-May-18 | Market Sale | 4,000 | $6.41 | $25,640.00 | (100%) 4.0K to 0 | 23% |
| 10-May-18 2:55 PM View: | Vishnoi Rohit Director | INSYS Therapeutics, Inc. (INSY) | 08-May-18 | Grant | 6,000 | -- | -- | 150% 4.0K to 10.0K | |
| 17-Apr-18 2:27 PM View: | Motahari Saeed President & CEO Director | INSYS Therapeutics, Inc. (INSY) | 17-Apr-18 | Grant | 11,000 | -- | -- | 71% 15.4K to 26.4K | |
| 23-Apr-19 7:14 PM View: | Vanhove Geertrui Director | INSYS Therapeutics, Inc. (INSY) | 02-Apr-18 | Grant Duplicate | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 19-Apr-19 9:30 PM View: | Vanhove Geertrui Director | INSYS Therapeutics, Inc. (INSY) | 02-Apr-18 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 23-Apr-19 7:09 PM View: | Lapalme Pierre Director | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant | 4,000 | -- | -- | 57% 7.0K to 11.0K | |
| 23-Apr-19 7:11 PM View: | Long Andrew G Chief Financial Officer | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant Duplicate | 10,600 | -- | -- | 106% 10.0K to 20.6K | |
| 23-Apr-19 7:10 PM View: | Meyer Steven J Director | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant | 4,000 | -- | -- | 7% 56.08K to 60.08K | |
| 23-Apr-19 7:12 PM View: | Motahari Saeed President & CEO Director | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant Duplicate | 16,000 | -- | -- | 29% 54.99K to 70.99K | |
| 19-Apr-19 9:46 PM View: | Vishnoi Rohit Director | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant | 6,000 | -- | -- | 60% 10.0K to 16.0K | |
| 19-Apr-19 9:32 PM View: | Lapalme Pierre Director | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant | 4,000 | -- | -- | 57% 7.0K to 11.0K | |
| 19-Apr-19 9:41 PM View: | Long Andrew G Chief Financial Officer | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant | 10,600 | -- | -- | 106% 10.0K to 20.6K | |
| 19-Apr-19 9:31 PM View: | Meyer Steven J Director | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant | 4,000 | -- | -- | 7% 56.08K to 60.08K | |
| 19-Apr-19 9:40 PM View: | Motahari Saeed President & CEO Director | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant | 16,000 | -- | -- | 29% 54.99K to 70.99K | |
| 23-Apr-19 7:07 PM View: | Vishnoi Rohit Director | INSYS Therapeutics, Inc. (INSY) | 05-Mar-18 | Grant Duplicate | 6,000 | -- | -- | 60% 10.0K to 16.0K | |
| 01-Mar-18 6:00 PM View: | John N Kapoor Trust Dated S... 10% Owner | INSYS Therapeutics, Inc. (INSY) | 27-Feb-18 | txn.Z.title | 42,536,100 | -- | -- | (100%) 42.59M to 56.29K | |
| 10-May-18 2:53 PM View: | Meyer Steven J Director | INSYS Therapeutics, Inc. (INSY) | 21-Feb-18 | Grant | 4,000 | -- | -- | 8% 52.08K to 56.08K | |
| 14-May-18 5:50 PM View: | Tambi Brian Director | INSYS Therapeutics, Inc. (INSY) | 21-Feb-18 | Grant | 4,000 | -- | -- | 100% 0 to 4.0K | |
| 10-May-18 2:54 PM View: | Lapalme Pierre Director | INSYS Therapeutics, Inc. (INSY) | 21-Feb-18 | Grant | 4,000 | -- | -- | 133% 3.0K to 7.0K | |
| 14-Aug-17 12:38 PM View: | John N Kapoor Trust Dated S... 10% Owner | INSYS Therapeutics, Inc. (INSY) | 11-Aug-17 | Market Purchase | 17,500 | $8.93 | $156,338.00 | < 1% 42.52M to 42.54M | (45%) |
| 10-Aug-17 2:42 PM View: | Motahari Saeed President & CEO Director | INSYS Therapeutics, Inc. (INSY) | 10-Aug-17 | Market Purchase | 5,500 | $8.92 | $49,056.20 | 56% 9.9K to 15.4K | (44%) |
| 04-Aug-17 5:33 PM View: | Fourteau Patrick Director | INSYS Therapeutics, Inc. (INSY) | 04-Aug-17 | Option Exercise | 10,000 | $1.62 | $16,200.00 | 17% 59.68K to 69.68K | |
| 14-Jun-17 3:19 PM View: | Motahari Saeed President & CEO Director | INSYS Therapeutics, Inc. (INSY) | 14-Jun-17 | Market Purchase | 5,400 | $11.10 | $59,955.10 | 120% 4.5K to 9.9K | (55%) |
| 02-Jun-17 3:14 PM View: | Vishnoi Rohit Director | INSYS Therapeutics, Inc. (INSY) | 01-Jun-17 | Market Purchase | 4,000 | $14.14 | $56,575.20 | 100% 0 to 4.0K | (65%) |
| 26-May-17 4:26 PM View: | Fourteau Patrick Director | INSYS Therapeutics, Inc. (INSY) | 26-May-17 | Option Exercise | 10,000 | $3.63 | $36,300.00 | 20% 49.68K to 59.68K |
